NewLink Genetics has received a notice of allowance for a Japanese patent entitled, Antitumor Vaccination Using Allogeneic Tumor Cells Expressing Alpha (1,3)-Galactosyltransferase. The patent contains pharmaceutical composition claims ...
Tags: NewLink Genetics, galactosyltransferase, antitumor vaccination